Pulsed electric field, also known as electroporation, is an exciting advancement in electrosurgery and life sciences that enables the development of numerous novel treatments. As a result, this ...

Coherent Sine-Burst Electroporation™ Platform demonstrates 100% procedural success and high freedom from AF in paroxysmal and persistent patients LAUSANNE, Switzerland and SAN DIEGO, Feb. 09, 2026 ...

EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá Medtech announced today that it has begun enrollment in their First-in-Human Clinical Trial “Coherent Sine Burst Electroporation (CSE) ...

- Funding will advance US and EU clinical studies of innovative pulsed field ablation system for treating atrial fibrillation - Argá Medtech’s CSE™ ablation system enables electrophysiologists to ...

Credit: Getty Images A discussion on the use of pulsed field ablation for paroxysmal and persistent atrial fibrillation with Andrea Natale, MD, FACC. In December 2023, the PulseSelect pulsed field ...

With the recent approvals of two pulsed-field ablation (PFA) systems, US physicians now have additional options for treating their patients with atrial fibrillation (AF). Even those who are balking at ...

Argá Medtech SA said patients in the first stage of enrollment for a first-in-human clinical trial have been safely and effectively treated with an ablation system for treating atrial fibrillation (AF ...

Boston Scientific’s electrophysiology business stumbled as competition from Medtronic, Johnson & Johnson, Abbott, and others in the pulsed-field ablation (PFA) space intensified. Marie Thibault, a ...

LAUSANNE, Switzerland and SAN DIEGO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Argá Medtech today announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial, demonstrating the ...

Coherent Sine-Burst Electroporation Platform demonstrates 100% procedural success and high freedom from AF in paroxysmal and persistent patients COHERENT-AF U.S. Investigational Device Exemption (IDE) ...